Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2026, titled "Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2026, titled "Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg".